Maravai Lifesciences Holdings (MRVI) Divestments (2021)

Maravai Lifesciences Holdings' (MRVI) quarterly Divestments came in at $120.7 million in Q3 2021.

Maravai Lifesciences Holdings (MRVI) Divestments (2021) Analysis & Trends

Maravai Lifesciences Holdings' Divestments history runs 1 years deep, the most recent figure standing at $120.7 million for Q3 2021.

  • On a quarterly basis, Divestments changed N/A year-over-year to $120.7 million in Q3 2021; TTM through Dec 2023 was $120.7 million, a N/A change from a year earlier, with the FY2022 full-year figure at $620000.0, down 99.48% from the prior year.
  • Divestments was little changed at $120.7 million in Q3 2021 per MRVI's latest filing.
  • Across five years, Divestments topped out at $120.7 million in Q3 2021 and bottomed at $120.7 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -32.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Maravai Lifesciences Holdings 1.03 Bn 1.02 Bn 33.70 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 120.70 Mn